Victoria Payne

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Vaccination, Vaccine Safety, Phase 1/2 +7

Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder

Jonathan Davidson, Victoria Payne, Kathryn M. Connor et al. · International Clinical Psychopharmacology · 2004 · 213 citations

Psychotherapy, Psychological Co-morbidities, Traumatology +23

Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia

Richard S.E. Keefe, Robert W. Buchanan, Robert M. Hamer et al. · Neuropsychopharmacology · 2009 · 190 citations · Full text

Proof-of-concept Trial, Psychoactive Drug, Psychiatry +14

The Use of Aripiprazole in Obsessive-Compulsive Disorder

Kathryn M. Connor, Victoria Payne, Kishore M. Gadde et al. · The Journal of Clinical Psychiatry · 2005 · 132 citations

Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects

Jennifer C. Naylor, Jason D. Kilts, Christine M. Hulette et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2010 · 80 citations · Full text

Neuropsychology, Alzheimer's Disease, Allopregnanolone Levels +12